ArticlePDF Available

The Effectiveness of 5% Tea Tree Oil cream, 10% Tea Tree Oil cream, and 5% Permethrin Cream for Scabies Treatment in Pediatric Patients

Authors:

Abstract and Figures

Background: Scabies, an infectious disease caused by Sarcoptes scabiei mites, is still one of the most common skin diseases found in developing countries, including Indonesia. The 5% permethrin cream for scabies treatment has been investigated as having 2–3 time to cure scabies. Tea Tree Oil (TTO) is one of the agents that has been proven to have acaricidal potential as an anti-inflammatory, antibacterial, and antipruritic agent. It has minimal side effects in topical use. Purpose: To evaluate the effectiveness of 5% TTO cream and 10% TTO cream in scabies treatment of pediatric patients. Methods: This was an experimental, analytical study with controlled clinical trial methods, and a double-blind, parallel design comparing 5% TTO cream (treatment 1), 10% TTO cream (treatment 2), with 5% permethrin cream (control) to children with scabies. Result: The 5% TTO cream gave a cure rate of 61.5% and was significantly different from the 5% permethrin cream groups with a p-value = 0.044 in the first week of the study. The 5% permethrin cream gave a cure rate of 15.4%, and the cure rate of 10% TTO cream was 53.8% in the first week of the study. Conclusion: There was a significant difference between the 5% TTO cream and 5% permethrin cream in the first week of the study. The highest and fastest cure rates were found in the 5% TTO cream treatment group.
Content may be subject to copyright.
The Effectiveness of 5% Tea Tree Oil cream, 10% Tea Tree Oil cream, and
5% Permethrin Cream for Scabies Treatment in Pediatric Patients
Chesia Christiani Liuwan1, Muhammad Yulianto Listiawan1, Dwi Murtiastutik1, Evy
Ervianti1, Sawitri1, Cita Rosita Sigit Prakoeswa1, Linda Astari1, Farhat Surya Ningrat2,
Kurniati3, Endang Wahyu Fitriani4, Irmadita Citrashanty1, Regitta Indira Agusni1,
Iskandar Zulkarnain1
1Department of Dermatology and Venereology, Faculty of Medicine Universitas Airlangga, dr.
Soetomo General Academic Teaching Hospital, Surabaya, Indonesia
2Syarifah Ambami Rato Ebu General Hospital, Bangkalan, Indonesia
3 Ibnu Sina Provincial General Hospital, Surabaya, Indonesia
4 Faculty of Pharmacy, Universitas Surabaya, Surabaya, Indonesia
ABSTRACT
Background: Scabies, an infectious disease caused by Sarcoptes scabiei mites, is still one of the most common skin diseases
found in developing countries, including Indonesia. The 5% permethrin cream for scabies treatment has been investigated as
having 23 time to cure scabies. Tea Tree Oil (TTO) is one of the agents that has been proven to have acaricidal potential as
an anti-inflammatory, antibacterial, and antipruritic agent. It has minimal side effects in topical use. Purpose: To evaluate the
effectiveness of 5% TTO cream and 10% TTO cream in scabies treatment of pediatric patients. Methods: This was an
experimental, analytical study with controlled clinical trial methods, and a double-blind, parallel design comparing 5% TTO
cream (treatment 1), 10% TTO cream (treatment 2), with 5% permethrin cream (control) to children with scabies. Result: The
5% TTO cream gave a cure rate of 61.5% and was significantly different from the 5% permethrin cream groups with a p-value
= 0.044 in the first week of the study. The 5% permethrin cream gave a cure rate of 15.4%, and the cure rate of 10% TTO
cream was 53.8% in the first week of the study. Conclusion: There was a significant difference between the 5% TTO cream
and 5% permethrin cream in the first week of the study. The highest and fastest cure rates were found in the 5% TTO cream
treatment group.
Keywords: scabies, tea tree oil, permethrin, children.
Correspondence: Iskandar Zulkarnain, Department of Dermatology and Venereology, Faculty of Medicine, Universitas
Airlangga/Dr. Soetomo General Academic Teaching Hospital, Jl. Mayjend Prof. Dr. Moestopo No. 6-8 Surabaya 60131,
Indonesia. Telepon: 0818309859, email: zuljazid@yahoo.com.
INTRODUCTION
Scabies, an infectious disease caused by
Sarcoptes scabiei mite, is still one of the most common
skin diseases found in developing countries, including
Indonesia. Every year, there are approximately 300
million cases of scabies in worldwide.1 Symptoms of
this disease are severe itching, especially at night with
clinical manifestations of papules and pustules
accompanied by tunnel-shaped lesions where S. scabiei
is lodged in the epidermis. Scabies also causes
complications such as rheumatic fever, nephritis, and
sepsis, which are caused by secondary infection by
Group A Streptococcus sp. or Staphylococcus aureus.2
Scabies is generally occurred in low economic areas,
areas with limited resource, and areas where people
have to live in close proximity such as prisons, nursing
homes, and dormitories. In addition, low socio-
economic conditions, lack of hygiene, crowded
neighborhoods, lack of nutrition, and sexual behavior
are risk factors for the spread of scabies.3
Although scabies is a highly prevalent disease and
potentially cause life-threatening complications, there
has been not enough attention that is still considered a
neglected disease. Treatment for scabies has now been
investigated to have alarming local and systemic side
effects, and its safety has not yet known in elderly
patients, patients with impaired liver function, in
patients younger than five years old, and in pregnant
women. Several studies conducted in Australia found
that the survival time of S. scabiei after exposure to
acaricide drugs has increased to 2 to 3 times compared
to 10 years ago.1
The diagnosis of scabies is made through clinical
manifestations and microscopic examination.
Identifying lesions can be difficult because it often
becomes unclear due to eczema or impetigo. A
presumptive diagnosis can be made based on a history
200
The Effectiveness of 5% Tea Tree Oil cream, 10% Tea Tree Oil cream, and
5% Permethrin Cream for Scabies Treatment in Pediatric Patients
Chesia Christiani Liuwan1, Muhammad Yulianto Listiawan1, Dwi Murtiastutik1, Evy
Ervianti1, Sawitri1, Cita Rosita Sigit Prakoeswa1, Linda Astari1, Farhat Surya Ningrat2,
Kurniati3, Endang Wahyu Fitriani4, Irmadita Citrashanty1, Regitta Indira Agusni1,
Iskandar Zulkarnain1
1Department of Dermatology and Venereology, Faculty of Medicine Universitas Airlangga, dr.
Soetomo General Academic Teaching Hospital, Surabaya, Indonesia
2Syarifah Ambami Rato Ebu General Hospital, Bangkalan, Indonesia
3 Ibnu Sina Provincial General Hospital, Surabaya, Indonesia
4 Faculty of Pharmacy, Universitas Surabaya, Surabaya, Indonesia
ABSTRACT
Background: Scabies, an infectious disease caused by Sarcoptes scabiei mites, is still one of the most common skin diseases
found in developing countries, including Indonesia. The 5% permethrin cream for scabies treatment has been investigated as
having 23 time to cure scabies. Tea Tree Oil (TTO) is one of the agents that has been proven to have acaricidal potential as
an anti-inflammatory, antibacterial, and antipruritic agent. It has minimal side effects in topical use. Purpose: To evaluate the
effectiveness of 5% TTO cream and 10% TTO cream in scabies treatment of pediatric patients. Methods: This was an
experimental, analytical study with controlled clinical trial methods, and a double-blind, parallel design comparing 5% TTO
cream (treatment 1), 10% TTO cream (treatment 2), with 5% permethrin cream (control) to children with scabies. Result: The
5% TTO cream gave a cure rate of 61.5% and was significantly different from the 5% permethrin cream groups with a p-value
= 0.044 in the first week of the study. The 5% permethrin cream gave a cure rate of 15.4%, and the cure rate of 10% TTO
cream was 53.8% in the first week of the study. Conclusion: There was a significant difference between the 5% TTO cream
and 5% permethrin cream in the first week of the study. The highest and fastest cure rates were found in the 5% TTO cream
treatment group.
Keywords: scabies, tea tree oil, permethrin, children.
Correspondence: Iskandar Zulkarnain, Department of Dermatology and Venereology, Faculty of Medicine, Universitas
Airlangga/Dr. Soetomo General Academic Teaching Hospital, Jl. Mayjend Prof. Dr. Moestopo No. 6-8 Surabaya 60131,
Indonesia. Telepon: 0818309859, email: zuljazid@yahoo.com.
INTRODUCTION
Scabies, an infectious disease caused by
Sarcoptes scabiei mite, is still one of the most common
skin diseases found in developing countries, including
Indonesia. Every year, there are approximately 300
million cases of scabies in worldwide.1 Symptoms of
this disease are severe itching, especially at night with
clinical manifestations of papules and pustules
accompanied by tunnel-shaped lesions where S. scabiei
is lodged in the epidermis. Scabies also causes
complications such as rheumatic fever, nephritis, and
sepsis, which are caused by secondary infection by
Group A Streptococcus sp. or Staphylococcus aureus.2
Scabies is generally occurred in low economic areas,
areas with limited resource, and areas where people
have to live in close proximity such as prisons, nursing
homes, and dormitories. In addition, low socio-
economic conditions, lack of hygiene, crowded
neighborhoods, lack of nutrition, and sexual behavior
are risk factors for the spread of scabies.3
Although scabies is a highly prevalent disease and
potentially cause life-threatening complications, there
has been not enough attention that is still considered a
neglected disease. Treatment for scabies has now been
investigated to have alarming local and systemic side
effects, and its safety has not yet known in elderly
patients, patients with impaired liver function, in
patients younger than five years old, and in pregnant
women. Several studies conducted in Australia found
that the survival time of S. scabiei after exposure to
acaricide drugs has increased to 2 to 3 times compared
to 10 years ago.1
The diagnosis of scabies is made through clinical
manifestations and microscopic examination.
Identifying lesions can be difficult because it often
becomes unclear due to eczema or impetigo. A
presumptive diagnosis can be made based on a history
of typical pruritus, pruritus that gets worse at night,
distribution of the lesion, and a history of contact with
other scabies patients. Definitive diagnosis is through
microscopic findings of scabies mites, eggs, pieces of
eggshell, or fecal matter (scybala) taken from a skin
scraping from papules or under the nails. On
dermoscopy, S. scabiei looks like a dark triangular
shape resembling the letter "V". In the absence of mites
found or negative dermoscopic examination, the
diagnosis is based on clinical findings and
epidemiology.4,5
Tea Tree Oil (TTO) is a derivate of essential oil
attained from the distillation of leaves and terminal
branches of the Melaleuca alternifolia plant. TTO is a
colorless or pale yellowish liquid, clear, and has a scent
of terpenes, conifer, and minty, camphoraceous. TTO
is an agent that has been proven in vivo and in vitro to
have an acaricidal potential. TTO has three main
components, namely terpinene-4-ol, γ-terpinene, and
α-terpinene, which has anti-inflammatory,
antibacterial, and antipruritic properties, with very
minimal side effects in topical use. Topical TTO
preparations will have several advantages as scabies
therapy, which are more economical, easy to use, and
can be implemented in various communities as a
traditional medicine.1
TTO has a promising acaricidal effect against
scabies mites in vitro. It has been used successfully as
a topical adjuvant treatment in the treatment of crusted
scabies, including cases that do not respond to standard
therapy. The combined effects of acaricidal,
antibacterial, antipruritic, anti-inflammatory, and
wound healing effects on TTO can potentially reduce
scabies infection due to bacterial complications.1,6 TTO
has been used as a remedy for several diseases such as
acne, eczema, skin infections such as herpes simplex
and warts, wounds, burns, insect bites, dandruff, and
nail mycosis.6 TTO as essential oil is also used as
therapy for dermatosis, respiratory infection, oral and
vaginal, and antiseptic and disinfectant.6
Terpinen-4-ol, at 0.125% concentration, can
inhibit the production of several inflammatory
mediators, such as tumor necrosis factor α, interleukin-
1β, and prostaglandin E2, equivalent to the production
of superoxide, thereby reducing the inflammatory
response. TTO has been shown to reduce the
inflammatory response to the skin, including responses
to insect bites, bee stings, hives/itches, and metal-
induced hypersensitivity. This is due to the ability of
TTO to modulate vasodilation and plasma
extravasation related to inflammation caused by
histamine.1,8
Various compounds in TTO have different use
profiles. For example, terpinen-4-ol, a major
component of TTO, exhibits strong anti-inflammatory,
antimicrobial and anti-tumor properties9, while 1.8-
cineole is an unwanted allergen in TTO products. The
anti-inflammatory activity of TTO is mediated by the
reduction of TNF α, IL-1, IL-8, prostaglandin E, and
superoxide monocytes. Topical TTO can regulate
wheal and flare by reducing histamine-induced edema.
TTO is an excellent alternative antioxidant. Its
antioxidant activity reflects the properties of α-
terpinene, α-terpinolene, and γ-terpinene.8
There are no studies that examine the
effectiveness of acaricide drugs. Permethrin 5% works
by blocking sodium channels in parasitic organs that
can cause paralysis and arthropod death. The
mechanism of the 5% TTO as an acaricide drug is
thought to be the same as that of other acaricide drugs,
blocking the sodium channel causing paralysis of the
arthropods.10 TTO is believed to block the parasitic
motility which causes elimination of the parasite from
the host. One example of an anti-parasitic drug,
Levamisole, works as an agonist on the nicotinic
acetylcholine receptor in the parasitic neuromuscular
junction, causing neuromuscular depolarization and
spastic paralysis of the parasite.8
The topical application of TTO has a low
incidence of side effects. The most frequent side effects
are irritant and allergic reactions to the oil. Irritant
reactions can be significantly avoided through a lower
concentration. Although the threshold limits for irritant
reactions have not been described, TTO with
concentrations below 25% is said to rarely cause side
effects.11,12
METHODS
This study was an experimental, analytical study
using controlled clinical trial methods, random pair
selection, and a double-blind, parallel design
comparing 5% TTO cream (treatment 1), 10% TTO
cream (treatment 2) with 5% permethrin cream
(control) on child scabies.
The inclusion criterion was scabies patients aged
5 to 16 years old who were willing to participate in the
study by signing informed consent. The diagnostic
criteria for scabies are the presence of a burrow in the
form of linear or winding and/or a typical scabies
lesion, i.e., the discovery of papules or pustules in the
area of scabies predilection, a complaint of itching,
especially at night, and similar complaints in the family
or close people were present, and/or the presence of
triangular structure in the form of the letter 'V' in a
dermoscopic examination, and/or one of the following
is obtained from light microscopy: eggs, larvae, lice, or
fleas. The exclusion criteria were patients with a
secondary infection, patients with severe systemic
201
Original Article
The Eectiveness of 5% Tea Tree Oil cream, 10% Tea Tree Oil cream,
and 5% Permethrin Cream for Scabies Treatment in Pediatric Patients
abnormalities, patients with immunosuppression, and
Norwegian/crusted scabies.
The sampling technique was consecutive,
selecting participants who pass the inclusion and
exclusion criteria at the Nurul Cholil Islamic Boarding
School in Bangkalan. A total of 39 samples were then
divided into three groups, and each group consisted of
13 people. The allocation of samples to the treatment
and control group was done randomly.
The procedure and objective of the study were
conveyed to the eligible samples and their guardians,
and if they are willing to participate in the research,
informed consent will be signed by the representative
of the Nurul Cholil boarding school, Bangkalan.
Subjects were interviewed, then underwent physical
examinations to measure weight and height, inspect
and palpate the location of the complaint, conduct a
dermoscopy examination, and dermal lesion scrapings.
The subjects were then prescribed with cream for night
use after they shower. The subjects applied the cream
all over their bodies, including the crease areas and
areas without complaints, as instructed. The cream was
left for 8 hours and rinsed in the following day. The
cream can be reapplied once a week if there is positive
sign of scabies, established by a doctor’s physical
examination.
In the following week, the first week, the first
evaluation included physical examination, dermoscopy
examination, and scrapping examination. If all
examinations showed negative results, the subject
would be declared cured. If one of the examinations
showed a positive result, the subject would be
prescribed with the cream for the second time (the first
repetition). The second evaluation was carried out in
the following week, the second week, using the same
method and criteria. Should the tests showed at least
one positive result, the subject would receive the
treatment for the third time (the second repetition) and
re-evaluate the following week, which was the last
evaluation. If one of the test results showed positive,
then the research subject would be declared not cured.
RESULTS
This research is a clinical trial conducted in
August to October 2019 aimed to compare the 5% TTO
cream and 10% TTO cream to 5% permethrin cream,
which has been used as standard therapy in treating
scabies in this research. Subjects who participated in
this study were patients who had positive results on
physical examination and positive results on either
scrapping or dermoscopic examinations for scabies
infection. Two positive results from the three
examinations aim to increase the diagnostic value of
scabies in this study. Thirty-nine subjects participated
in this study, and they were divided into 3 treatment
groups, consisting of 13 participants each group. Each
group received 5% permethrin cream, 5% TTO cream,
10% TTO cream, respectively. This was a double-blind
study in which the creams had identical packaging and
numbered accordingly. Therefore, only the researcher
knew which cream was which.
Table 1 shows that most research subjects were
males, amounting to 82.1%. The Pearson Chi-Square
test shows a value of p = 0.498, which means that the
data distribution of sex in the three study groups was
not different. The high prevalence of scabies in male
children was possible because of the sex ratio. There
were 2,000 males and 1,200 females in Nurul Cholil
Islamic boarding school. Also, males’ poorer self-
hygiene and care may contribute to the disease.
Females tend to be more attentive to complaints and are
responsive to seek treatment compared to males. Poor
self-hygiene behaviors include sharing towels, sharing
bed which facilitates skin-to-skin contact with scabies
sufferers, and not immediately wash clothes after use.13
The age range of the subjects was 1016 years
old. A retrospective study conducted by Paramita in
2015 on scabies in the Dermatology and Venerology
Outpatient Clinic of Dr. Soetomo General Academic
Hospital, Surabaya states that the highest prevalence
(63.8% of 282 patients) of scabies was observed in 4
14 years age group.14 Kruskal Wallis p score was 0.257,
which means that no difference in terms of age range
between the study groups. This was because the
majority of research subjects were in the same age
group (early teens), where someone has begun to
understand pay attention to their health. Early
adolescence is a turning point age where someone
interacts more with other people. Scabies that infects
skin between fingers and toes and are visible. This can
cause embarrassment and inferiority. As many as 80%
of scabies patients claim that this disease affects their
quality of life, including sleep disorders, community
stigma, and causes shame.15,16
Table 2 shows the comparison of cure rates
between 5% permethrin cream and 5% TTO cream.
The cure rate of 5% permethrin cream was 15.4%, and
the cure rate of 5% TTO cream was 61.5%. The
statistical analysis using the Pearson Chi-square test
showed a p-value of 0.044. It means that there were
significant differences between the two groups.
The statistical analysis of the 5% Permethrin
cream and 10% TTO cream resulted in a p-value of
0.097. It means that there was no significant difference
between the two groups. The 5% permethrin cream had
a cure rate of 15.4%, and the 10% TTO cream had a
53.8% cure rate. A similar result was obtained from a
comparison between 5% TTO cream and 10% TTO
Berkala Ilmu Kesehatan Kulit dan Kelamin – Periodical of Dermatology and Venereology Vol. 32 / No. 3 / December 2020
202
abnormalities, patients with immunosuppression, and
Norwegian/crusted scabies.
The sampling technique was consecutive,
selecting participants who pass the inclusion and
exclusion criteria at the Nurul Cholil Islamic Boarding
School in Bangkalan. A total of 39 samples were then
divided into three groups, and each group consisted of
13 people. The allocation of samples to the treatment
and control group was done randomly.
The procedure and objective of the study were
conveyed to the eligible samples and their guardians,
and if they are willing to participate in the research,
informed consent will be signed by the representative
of the Nurul Cholil boarding school, Bangkalan.
Subjects were interviewed, then underwent physical
examinations to measure weight and height, inspect
and palpate the location of the complaint, conduct a
dermoscopy examination, and dermal lesion scrapings.
The subjects were then prescribed with cream for night
use after they shower. The subjects applied the cream
all over their bodies, including the crease areas and
areas without complaints, as instructed. The cream was
left for 8 hours and rinsed in the following day. The
cream can be reapplied once a week if there is positive
sign of scabies, established by a doctor’s physical
examination.
In the following week, the first week, the first
evaluation included physical examination, dermoscopy
examination, and scrapping examination. If all
examinations showed negative results, the subject
would be declared cured. If one of the examinations
showed a positive result, the subject would be
prescribed with the cream for the second time (the first
repetition). The second evaluation was carried out in
the following week, the second week, using the same
method and criteria. Should the tests showed at least
one positive result, the subject would receive the
treatment for the third time (the second repetition) and
re-evaluate the following week, which was the last
evaluation. If one of the test results showed positive,
then the research subject would be declared not cured.
RESULTS
This research is a clinical trial conducted in
August to October 2019 aimed to compare the 5% TTO
cream and 10% TTO cream to 5% permethrin cream,
which has been used as standard therapy in treating
scabies in this research. Subjects who participated in
this study were patients who had positive results on
physical examination and positive results on either
scrapping or dermoscopic examinations for scabies
infection. Two positive results from the three
examinations aim to increase the diagnostic value of
scabies in this study. Thirty-nine subjects participated
in this study, and they were divided into 3 treatment
groups, consisting of 13 participants each group. Each
group received 5% permethrin cream, 5% TTO cream,
10% TTO cream, respectively. This was a double-blind
study in which the creams had identical packaging and
numbered accordingly. Therefore, only the researcher
knew which cream was which.
Table 1 shows that most research subjects were
males, amounting to 82.1%. The Pearson Chi-Square
test shows a value of p = 0.498, which means that the
data distribution of sex in the three study groups was
not different. The high prevalence of scabies in male
children was possible because of the sex ratio. There
were 2,000 males and 1,200 females in Nurul Cholil
Islamic boarding school. Also, males’ poorer self-
hygiene and care may contribute to the disease.
Females tend to be more attentive to complaints and are
responsive to seek treatment compared to males. Poor
self-hygiene behaviors include sharing towels, sharing
bed which facilitates skin-to-skin contact with scabies
sufferers, and not immediately wash clothes after use.13
The age range of the subjects was 1016 years
old. A retrospective study conducted by Paramita in
2015 on scabies in the Dermatology and Venerology
Outpatient Clinic of Dr. Soetomo General Academic
Hospital, Surabaya states that the highest prevalence
(63.8% of 282 patients) of scabies was observed in 4
14 years age group.14 Kruskal Wallis p score was 0.257,
which means that no difference in terms of age range
between the study groups. This was because the
majority of research subjects were in the same age
group (early teens), where someone has begun to
understand pay attention to their health. Early
adolescence is a turning point age where someone
interacts more with other people. Scabies that infects
skin between fingers and toes and are visible. This can
cause embarrassment and inferiority. As many as 80%
of scabies patients claim that this disease affects their
quality of life, including sleep disorders, community
stigma, and causes shame.15,16
Table 2 shows the comparison of cure rates
between 5% permethrin cream and 5% TTO cream.
The cure rate of 5% permethrin cream was 15.4%, and
the cure rate of 5% TTO cream was 61.5%. The
statistical analysis using the Pearson Chi-square test
showed a p-value of 0.044. It means that there were
significant differences between the two groups.
The statistical analysis of the 5% Permethrin
cream and 10% TTO cream resulted in a p-value of
0.097. It means that there was no significant difference
between the two groups. The 5% permethrin cream had
a cure rate of 15.4%, and the 10% TTO cream had a
53.8% cure rate. A similar result was obtained from a
comparison between 5% TTO cream and 10% TTO
cream, as shown in Table 4, with a p-value of 1.000. It
means no significant difference between the two
groups.
Table 1. Characteristics of the research subjects
Variable
Permethrin 5%,
n=13
TTO 5%,
n=13
TTO 10%,
n=13 p-Value
Sex
Male
Female
12 (92.3%)
1 (7.7%)
10 (76.9%)
3 (23.1%)
10(76.9%)
3 (23.1%)
p=0.498
(Chi Square)
Age (years)
10
11
12
13
14
15
16
0 (0%)
0 (0%)
1 (7.7%)
6 (46.15%)
1 (7.7%)
3 (23.1%)
2 (15.35%)
0 (0%)
0 (0%)
0 (0%)
2 (15.35%)
5 (38.5%)
2 (15.35%)
4 (30.8%)
1 (7.7%)
1 (7.7%)
3 (23.1%)
1 (7.7%)
2 (15.35%)
2 (15.35%)
3 (23.1%)
p=0.257
(Kruskal
Wallis)
Nutritional status
(BMI, kg/m2)
Underweight
(BMI <18.5)
Normal
(BMI 18.522.9)
Overweight
(BMI 2329.9)
Obese (BMI >30)
5 (38.5%)
8 (61.5%)
0 (0%)
0 (0%)
8 (61.5%)
5 (38.5%)
0 (0%)
0 (0%)
7 (53.85%)
4 (30.8%)
2 (15.35%)
0 (0%)
p=0.740
(Oneway
ANOVA)
BMI= Body Mass Index; TTO= Tea Tree Oil
Table 2. Treatment outcomes of 5% permethrin cream and 5% Tea Tree Oil cream
Week 1
Week 2
Week 3
(n=13)
(n=11)
(n=8)
2 (15.4%)
3 (27.3%)
3 (37.5%)
11 (84.6%)
8 (72.7%)
5 (62.5%)
(n=13)
(n=5)
(n=2)
8 (61.5%)
3 (60%)
0 (0%)
5 (38.5%)
2 (40%)
2 (100%)
0.044
TTO = Tea Tree Oil
Table 3. Treatment outcomes of 5% permethrin cream and 10% Tea Tree Oil cream
Week 1
Week 2
Week 3
Permethrin 5%
(n=13)
(n=11)
(n=8)
Cured
2 (15.4%)
3 (27.3%)
3 (37.5%)
Not cured
11 (84.6%)
8 (72.7%)
5 (62.5%)
TTO 10%
(n=13)
(n=6)
(n=5)
Cured
7 (53.8%)
1 (16.7%)
0 (0%)
Not cured
6 (46.2%)
5 (83.3%)
5 (100%)
p value (Chi Square)
0.097
TTO= Tea Tree Oil
203
Original Article
The Eectiveness of 5% Tea Tree Oil cream, 10% Tea Tree Oil cream,
and 5% Permethrin Cream for Scabies Treatment in Pediatric Patients
Table 4. Treatment outcomes of 5% Tea Tree Oil cream and 10% Tea Tree Oil cream
Week 1
Week 2
Week 3
TTO 5% cream
(n=13)
(n=5)
(n=2)
Cured
8 (61.5%)
3 (60%)
0 (0%)
Not cured
5 (38.5%)
2 (40%)
2(100%)
TTO 10%
(n=13)
(n=6)
(n=5)
Cured
7 (53.8%)
1 (16.7%)
0 (0%)
Not cured
6 (46.2%)
5 (83.3%)
5(100%)
p value (Chi Square)
1.000
TTO= Tea Tree Oil
Tabel 5. Treatment outcomes of each group in each week of evaluation
Treatment
Week 1
(n=39)
Week 2
(n=22)
Week 3
(n=15)
Permethrin 5%
2 (5.1%)
3 (13.6%)
3 (20%)
TTO 5%
8 (20.5%)
3 (13.6%)
0 (0%)
TTO 10%
7 (17.9%)
1 (4.5%)
0 (0%)
Total
17(43.5%)
7 (31.8%)
3 (20%)
TTO = Tea Tree Oil
Table 5 shows that the highest and fastest cure
rates were found in the 5% TTO cream, a treatment
group. In the first week of treatment, the 5% TTO
group had the highest cure rate compared to the other
two groups, which was 20.5% with a p-value of 0.044,
indicating no significant difference between the 5%
TTO cream group and the 5% permethrin cream. This
was possibly because of Terpinen-4-ol found in TTO,
which works by inhibiting the production of
inflammatory mediators and paralyzing arthropods by
blocking the sodium channel and the nicotinic
acetylcholine receptor agonist in the neuromuscular
junction of S. scabiei. Permethrin 5% only paralyzes S.
scabiei; therefore, it makes sense that TTO can cure
scabies more quickly. The use of 5% permethrin cream
in treating scabies also gives excellent and satisfying
results. The 5% permethrin cream is the most widely
used first-line topical drug for scabies treatment, and
some countries use it as the gold standard of therapy.
Research conducted by Goldust found that treatment
using 5% permethrin achieved a cure rate of 92.5% in
the second week of treatment.10
This study concluded that there were significant
differences between 5% TTO cream and 5%
permethrin cream in scabies treatment in the first week.
Environment is one of the factors that could not be
controlled in this study. Dense populations and close
interactions can cause reinfection and hinder the
healing process. Environmental control, such as
personal hygiene and comprehensive management, can
increase the successful rate of therapy.
REFERENCES
1. Thomas J, Carson CF, Peterson GM, Walton SF,
Hammer KA, Naunton M, et al. Review article
therapeutic potential of tea tree oil for scabies.
Am J Trop Med Hyg 2016; 94: 25866.
2. Hay RJ, Steer AC, Engelman, Walton S. Skabies
in the developing world-its prevalence,
complications, and management. Clin Microbiol
Infect 2012; 18: 31323.
3. Lassa S, Campbell MJ, Bennett CE.
Epidemiology of skabies prevalence in the UK.
from general practice records. Br J Dermatol
2011; 164: 132934.
4. Park JH, Kim CW, Kim SS. The diagnostic
accuracy of dermoscopy for skabies. Ann
Dermatol 2012; 24: 1949.
5. Walter B, Heukelbach J, Fengler G, Worth C,
Hengge U, Feldmeier H. Comparison of
dermoscopy, skin scraping, and the adhesive tape
test for the diagnosis of skabies in a resource-poor
setting. Arch Dermatol 2011; 147-68.
6. Groot AC De, Schmidt E. Tea tree oil : contact
allergy and chemical composition. Contact
Dermatitis 2016; 75: 115.
7. Lee C, Chen L, Chang T, Huang C, Huang M,
Wang C. Correlations of the components of tea
tree oil with its antibacterial effects and skin
irritation. J Food Drug Anal 2013; 21: 16976.
8. Pazyar N, Yaghoobi R, Bagherani N, Kazerouni
A. Review A review of applications of tea tree oil
in dermatology. Int J Dermatol 2012; 52: 17.
9. Tighe S, Gao Y, Tseng SCG. Terpinen-4-ol is the
Berkala Ilmu Kesehatan Kulit dan Kelamin – Periodical of Dermatology and Venereology Vol. 32 / No. 3 / December 2020
204
Table 4. Treatment outcomes of 5% Tea Tree Oil cream and 10% Tea Tree Oil cream
Week 1
Week 2
Week 3
TTO 5% cream
(n=13)
(n=5)
(n=2)
Cured
8 (61.5%)
3 (60%)
0 (0%)
Not cured
5 (38.5%)
2 (40%)
2(100%)
TTO 10%
(n=13)
(n=6)
(n=5)
Cured
7 (53.8%)
1 (16.7%)
0 (0%)
Not cured
6 (46.2%)
5 (83.3%)
5(100%)
p value (Chi Square)
1.000
TTO= Tea Tree Oil
Tabel 5. Treatment outcomes of each group in each week of evaluation
Treatment
Week 1
(n=39)
Week 2
(n=22)
Week 3
(n=15)
Permethrin 5%
2 (5.1%)
3 (13.6%)
3 (20%)
TTO 5%
8 (20.5%)
3 (13.6%)
0 (0%)
TTO 10%
7 (17.9%)
1 (4.5%)
0 (0%)
Total
17(43.5%)
7 (31.8%)
3 (20%)
TTO = Tea Tree Oil
Table 5 shows that the highest and fastest cure
rates were found in the 5% TTO cream, a treatment
group. In the first week of treatment, the 5% TTO
group had the highest cure rate compared to the other
two groups, which was 20.5% with a p-value of 0.044,
indicating no significant difference between the 5%
TTO cream group and the 5% permethrin cream. This
was possibly because of Terpinen-4-ol found in TTO,
which works by inhibiting the production of
inflammatory mediators and paralyzing arthropods by
blocking the sodium channel and the nicotinic
acetylcholine receptor agonist in the neuromuscular
junction of S. scabiei. Permethrin 5% only paralyzes S.
scabiei; therefore, it makes sense that TTO can cure
scabies more quickly. The use of 5% permethrin cream
in treating scabies also gives excellent and satisfying
results. The 5% permethrin cream is the most widely
used first-line topical drug for scabies treatment, and
some countries use it as the gold standard of therapy.
Research conducted by Goldust found that treatment
using 5% permethrin achieved a cure rate of 92.5% in
the second week of treatment.10
This study concluded that there were significant
differences between 5% TTO cream and 5%
permethrin cream in scabies treatment in the first week.
Environment is one of the factors that could not be
controlled in this study. Dense populations and close
interactions can cause reinfection and hinder the
healing process. Environmental control, such as
personal hygiene and comprehensive management, can
increase the successful rate of therapy.
REFERENCES
1. Thomas J, Carson CF, Peterson GM, Walton SF,
Hammer KA, Naunton M, et al. Review article
therapeutic potential of tea tree oil for scabies.
Am J Trop Med Hyg 2016; 94: 25866.
2. Hay RJ, Steer AC, Engelman, Walton S. Skabies
in the developing world-its prevalence,
complications, and management. Clin Microbiol
Infect 2012; 18: 31323.
3. Lassa S, Campbell MJ, Bennett CE.
Epidemiology of skabies prevalence in the UK.
from general practice records. Br J Dermatol
2011; 164: 132934.
4. Park JH, Kim CW, Kim SS. The diagnostic
accuracy of dermoscopy for skabies. Ann
Dermatol 2012; 24: 1949.
5. Walter B, Heukelbach J, Fengler G, Worth C,
Hengge U, Feldmeier H. Comparison of
dermoscopy, skin scraping, and the adhesive tape
test for the diagnosis of skabies in a resource-poor
setting. Arch Dermatol 2011; 147-68.
6. Groot AC De, Schmidt E. Tea tree oil : contact
allergy and chemical composition. Contact
Dermatitis 2016; 75: 115.
7. Lee C, Chen L, Chang T, Huang C, Huang M,
Wang C. Correlations of the components of tea
tree oil with its antibacterial effects and skin
irritation. J Food Drug Anal 2013; 21: 16976.
8. Pazyar N, Yaghoobi R, Bagherani N, Kazerouni
A. Review A review of applications of tea tree oil
in dermatology. Int J Dermatol 2012; 52: 17.
9. Tighe S, Gao Y, Tseng SCG. Terpinen-4-ol is the
most active ingredient of tea tree oil to kill
demodex mites. Translasional vision science &
technology 2013; 2: 205.
10. Zulkarnain I, Agusni RI, Hidayati AN.
Comparison of tea tree oil 5 % cream , tea tree oil
5 % + permethrin 5 % Cream , and permethrine 5
% cream in child scabies. International Journal of
Clinical and Experimental Medical Sciences
2019; 4: 8793.
11. Thomas J, Davey R, Peterson GM, Carson C,
Walton SF, Spelman T, et al. Treatment of
skabies using a tea tree oil-based gel formulation
in Australian Aboriginal children: protocol for a
randomised controlled trial. BMJ Open 2018; 8:
e018507.
12. Thomas J, Peterson GM, Walton SF, Carson CF,
Naunton M, Baby KE. Skabies: an ancient global
disease with a need for new therapies. BMC
Infect Dis 2015; 15(1): 250-255.
13. Sianturi I, Sungkar S. The relationship between
hygienic practices and skabies infestation in a
boarding school in East Jakarta. eJKI 2014; 2(2):
91-5.
14. Paramita K, Sawitri. Profil skabies pada anak.
BIKKK 2015; 27(1): 41-7.
15. Heukelbach J, Mazigo HD, Ugbomoiko US.
Impact of scabies in resource-poor communities.
Curr Opin Infect Dis 2013; 26: 12732.
16. Engelman D, Steer CA. Control Strategies for
skabies. Trop Med Infect Dis 2018; 3(98): 1-11.
205
Original Article
The Eectiveness of 5% Tea Tree Oil cream, 10% Tea Tree Oil cream,
and 5% Permethrin Cream for Scabies Treatment in Pediatric Patients
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
Scabies is a neglected tropical disease of the skin, causing severe itching and stigmatizing skin lesions. Further, scabies leads to impetigo, severe bacterial infections, and post-infectious complications. Around 200 million people are affected, particularly among disadvantaged populations living in crowded conditions in tropical areas. After almost 50 years, research into scabies control has shown great promise, particularly in highly-endemic island settings, but these findings have not been widely adopted. Newer approaches, utilizing ivermectin-based mass drug administration, appear feasible and highly effective. Inclusion of scabies in the WHO portfolio of neglected tropical diseases in 2017 may facilitate renewed opportunities and momentum toward global control. However, further operational research is needed to develop evidence-based strategies for control in a range of settings, and monitor their impact. Several enabling factors are required for successful implementation, including availability of affordable drug supply. Integration with existing health programs may provide a cost-effective approach to control.
Article
Full-text available
Introduction In remote Aboriginal communities in Australia, scabies affects 7 out of 10 children before their first birthday. This is more than six times the rate seen in the rest of the developed world. Scabies infestation is frequently complicated by bacterial infection, leading to the development of skin sores and other more serious consequences, such as septicaemia and chronic heart and kidney diseases. Tea tree oil (TTO) has been used as an antimicrobial agent for several decades with proven clinical efficacy. Preclinical investigations have demonstrated superior scabicidal properties of TTO compared with widely used scabicidal agents, such as permethrin 5% cream and ivermectin. However, current data are insufficient to warrant a broad recommendation for its use for the management of scabies because previous studies were small or limited to in vitro observations. Methods and analysis A pragmatic first trial will examine the clinical efficacy of a simple and low-cost TTO treatment against paediatric scabies and the prevention of associated secondary bacterial infections, with 1:1 randomisation of 200 participants (Aboriginal children, aged 5–16 years and living in remote Australia) into active control (permethrin 5% cream) and treatment (5% TTO gel) groups. The primary outcome for the study is clinical cure (complete resolution). Secondary outcome measures will include relief of symptoms, recurrence rate, adverse effects, adherence to treatment regimen and patient acceptability. Ethics and dissemination The project has received approvals from the University of Canberra Human Research Ethics Committee (HREC 16-133), Wurli-Wurlinjang Health Service Indigenous subcommittee and the Aboriginal Medical Services Alliance Northern Territory reference group. The results of this study will be published in core scientific publications, with extensive knowledge exchange activities with non-academic audiences throughout the duration of the project. Trial registration ACTRN12617000902392; Pre-results.
Article
Full-text available
Scabies is an ancient disease (documented as far back as 2500 years ago). It affects about 300 million people annually worldwide, and the prevalence is as high as about 60 % in Indigenous and Torres Strait Islander children in Australia. This is more than six times the rate seen in the rest of the developed world. Scabies is frequently complicated by bacterial infection leading to the development of skin sores and other more serious consequences such as septicaemia and chronic heart and kidney diseases. This causes a substantial social and economic burden especially in resource poor communities around the world. Very few treatment options are currently available for the management of scabies infection. In this manuscript we briefly discuss the clinical consequences of scabies and the problems found (studies conducted in Australia) with the currently used topical and oral treatments. Current scabies treatment options are fairly ineffective in preventing treatment relapse, inflammatory skin reactions and associated bacterial skin infections. None have ovicidal, antibacterial, anti-inflammatory and/or anti-pruritic properties. Treatments which are currently available for scabies can be problematic with adverse effects and perhaps of greater concern the risk of treatment failure. The development of new chemical entities is doubtful in the near future. Though there may be potential for immunological control, the development of a vaccine or other immunotherapy modalities may be decades away. The emergence of resistance among scabies mites to classical scabicides and ineffectiveness of current treatments (in reducing inflammatory skin reactions and secondary bacterial infections associated with scabies), raise serious concerns regarding current therapy. Treatment adherence difficulties, and safety and efficacy uncertainties in the young and elderly, all signal the need to identify new treatments for scabies.
Article
Full-text available
To determine the active ingredient in tea tree oil (TTO) responsible for its reported killing effect on Demodex mites, the most common ectoparasite found in the human skin extending to the eye. Using a reported in vitro killing assay to measure the survival time of adult Demodex folliculorum up to 150 minutes, we have screened serial concentrations of 13 of the 15 known ingredients of TTO (ISO4730:2004) that were soluble in mineral oil and examined their synergistic relationships in killing mites. The most potent ingredient was then tested for its efficacy in killing Demodex in vivo. All ingredients exhibited a dose-dependent killing effect. Besides Terpinen-4-ol, the order of relative potency did not correlate with the order of relative abundance in TTO for the remaining 12 ingredients. Terpinen-4-ol was the most potent ingredient followed by α-Terpineol, 1,8-Cineole and Sabinene. Terpinen-4-ol, the most abundant ingredient in TTO, was more potent than TTO at equivalent concentrations and its killing effect was even observable at a mere concentration of 1%. Terpinen-4-ol exhibited a significant synergistic effect with Terpinolene, but an antagonistic effect with α-Terpineol in killing mites (both P < 0.05). In vivo, Terpinen-4-ol was shown to eradicate mites. The above finding suggests that deployment of Terpinen-4-ol alone should enhance its potency in killing Demodex mites by reducing the adverse and antagonistic effects from other ingredients in TTO. Terpinen-4-ol can be adopted in future formulations of acaricides to treat a number of ocular and cutaneous diseases caused by demodicosis.
Article
Full-text available
Scabies is a contagious skin infestation characterized clinically by nocturnal pruritus, visible burrows and contagiousness. Dermoscopy has been suggested as an alternative for diagnosing scabies. But, there have been few well-designed studies evaluating the diagnostic accuracy of dermoscopy. We tried to confirm the diagnostic accuracy of dermoscopy for diagnosing scabies. We also tried to demonstrate specific circumstances in which dermoscopic identification of mites ("with dermoscopy") is more useful in diagnosing scabies, and to identify the specific clinical findings that could be used as a possible marker in diagnosing scabies. We compared the scraping procedure "with dermoscopy" and "without it" in 49 patients, measuring the duration and outcome of each procedure. Also, we tried to find the specific clinical factors associated with our objects. The skin scraping "with dermoscopy" was superior to "without it" with respect to the duration and accuracy of the procedure. A history of previous steroid treatment was associated with the superiority of dermoscopy. The correlation between the presence of visible burrows and the positive outcomes of "with dermoscopy" was statistically significant. Skin scraping with dermoscopy is implicated as the diagnostic method of choice for scabies at the present time. Dermoscopy is especially useful in diagnosis of incognito scabies. In addition, the presence of visible burrows could be a reliable positive marker of scabies in the absence of dermoscopy or microscopy data.
Article
Scabies is a skin disease that is most common in Indonesia, especially in dense environments such as boarding occupants. This research aims to study the relationship of scabies with personal hygienic practices (PHB) in the male students in the boarding school X in East Jakarta. This cross­ sectional study was conducted on March 8, 2014, and all students are the subjects of study (total sampling). Diagnosis of scabies was done with history taking and dermatological examination. PHB data was taken with a questionnaire containing 10 questions regarding the personal hygienic practices. The question was given a score of 0 to 1 for bad behavior and good behavior. Data were analyzed by chi square test. The results showed the prevalence of scabies was 36%, with 3.4% of good personal hygienic practices and 32.8% had poor personal hygienic practices. There are associated with scabies. Keywords: scabies, personal hygiene, prevalence, pesantren AbstrakSkabies merupakan salah satu penyakit kulit yang paling umum di Indonesia, terutama di ling­kungan padat penghuni seperti pesantren. Penelitian ini bertujuan untuk mempelajari hubungan skabies dengan perilaku hidup bersih (PHB) pada siswa laki­laki di Pesantren X di Jakarta Timur. Penelitian cross­sectional ini dilakukan pada tanggal 8 Maret 2014 dan semua siswa dijadikan sub­yek penelitian (total sampling). Diagnosis skabies dilakukan dengan anamnesis dan pemeriksaan dermatologis. Data PHB diambil dengan kuesioner yang berisi 10 pertanyaan mengenai PHB. Pertanyaan diberi skor 0 untuk perilaku buruk dan 1 untuk perilaku baik. Analisis data dilakukan dengan ujichi square. Hasilnya menunjukkan prevalensi skabies adalah 36% dan PHB yang baik (p=0.008). Disimpulkan, kebersihan pribadi berhubungan dengan skabies. Kata Kunci: scabies, perilaku hidup bersih, prevalensi, pesantren.
Article
In this article, contact allergy to, and the chemical composition of, tea tree oil (TTO) are reviewed. This essential oil is a popular remedy for many skin diseases, and may be used as neat oil or be present in cosmetics, topical pharmaceuticals and household products. Of all essential oils, TTO has caused most (published) allergic reactions since the first cases were reported in 1991. In routine testing, prevalences of positive patch test reactions have ranged from 0.1% to 3.5%. Nearly 100 allergic patients have been described in case reports and case series. The major constituents of commercial TTO are terpinen-4-ol, γ-terpinene, 1,8-cineole, α-terpinene, α-terpineol, p-cymene, and α-pinene. Fresh TTO is a weak to moderate sensitizer, but oxidation increases its allergenic potency. The major sensitizers appear to be ascaridole, terpinolene, α-terpinene, 1,2,4-trihydroxymenthane, α-phellandrene, and limonene. The clinical picture of allergic contact dermatitis caused by TTO depends on the products used. Most reactions are caused by the application of pure oil; cosmetics are the culprits in a minority of cases. Patch testing may be performed with 5% oxidized TTO. Co-reactivity to turpentine oil is frequent, and there is an overrepresentation of reactions to fragrance mix I, Myroxylon pereirae, colophony, and other essential oils.
Article
Tea tree oil (TTO), the essential oil of Melaleuca alternifolia L., is one of the most popular agents used in cosmetics. This study aimed to explore the correlations of components in TTO with its anti-acne activities and skin irritation. TTOs were isolated from the leaves (TTO-L), twigs, and branches of M. alternifolia by steam distillation, and the components analyzed by gas chromatography-mass spectrometry. Results showed that components of TTO-L satisfied the International Organization for Standardization (ISO) 4730 guidelines. TTO-L and its components, terpinen-4-ol, terpinolene, a-terpinene, and a-terpineol, had strong inhibitory activities against Propionibacterium acnes and Staphylococcus aureus. Moreover, six TTO formulas (DF-TTO) were designed according to ISO 4730 guidelines by adjusting the proportions of these four active components. All DF-TTO formulas showed a positive correlation between terpinen-4-ol concentration and anti-P. acnes activity. In the skin irritation assay, TTO-L, terpinen-4-ol, and 1,8-cineole did not cause significant skin irritation at 2% per site. In conclusion, terpinen-4-ol is the major active component responsible for TTO's antibacterial efficacy, while minor components in TTO also contributed to its efficacy. Moreover, we suggest that a concentration less than 5% is more suitable and safer for treating acne than higher concentrations. Copyright
Article
Tea tree oil (TTO) is an essential oil, steam-distilled from the Australian native plant, Melaleuca alternifolia. It has a minimum content of terpinen-4-ol and a maximum content of 1, 8-cineole. Terpinen-4-ol is a major TTO component which exhibits strong antimicrobial and anti-inflammatory properties. Tea tree oil exerts antioxidant activity and has been reported to have broad-spectrum antimicrobial activity against bacterial, viral, fungal, and protozoal infections affecting skin and mucosa. Several studies have suggested the uses of TTO for the treatment of acne vulgaris, seborrheic dermatitis, and chronic gingivitis. It also accelerates the wound healing process and exhibits anti-skin cancer activity. This review opens up new horizons for dermatologists in the use of this herbal agent.
Article
Purpose of review: Features of endemic scabies are specific in resource-poor and underprivileged communities, with implications for control measures on the community level. In this review, these special aspects are addressed. Recent findings: Scabies is endemic in many resource-poor communities, with a prevalence of 20% and higher. Transmission is influenced by social attitudes, migration, access to healthcare services, housing conditions, hygiene conditions, and crowding. Endemic scabies occurs with severe infestations, complications, and sequels, mainly in children. Sleep loss as a result of scabies-related itching is common. Complications include secondary infections by group A streptococci and acute poststreptococcal glomerulonephritis. Shame, restriction of leisure activities, and stigmatization are common. Treatment of scabies includes a variety of topical compounds, but control on the community level is not an easy task. As ivermectin kills a variety of other parasites, this oral drug is increasingly used for mass treatment. Intervention should address socioemotional aspects using an integrated approach with professionals from different areas, and the community. Summary: Scabies is a neglected disease and needs to be perceived as an important public health problem causing morbidity in many resource-poor communities. Future work on epidemiology, clinical aspects, transmission dynamics, socioeconomic aspects, and sustainable control in resource-poor communities is needed.